Cargando…

Urinary α(1)-Antichymotrypsin: A Biomarker of Prion Infection

The occurrence of blood-borne prion transmission incidents calls for identification of potential prion carriers. However, current methods for intravital diagnosis of prion disease rely on invasive tissue biopsies and are unsuitable for large-scale screening. Sensitive biomarkers may help meeting thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miele, Gino, Seeger, Harald, Marino, Denis, Eberhard, Ralf, Heikenwalder, Mathias, Stoeck, Katharina, Basagni, Max, Knight, Richard, Green, Alison, Chianini, Francesca, Wüthrich, Rudolf P., Hock, Christoph, Zerr, Inga, Aguzzi, Adriano
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2586086/ https://www.ncbi.nlm.nih.gov/pubmed/19057641 http://dx.doi.org/10.1371/journal.pone.0003870

Ejemplares similares

Lymphotoxin, but Not TNF, Is Required for Prion Invasion of Lymph Nodes
por: O'Connor, Tracy, et al.
Publicado: (2012)

Repetitive Immunization Enhances the Susceptibility of Mice to Peripherally Administered Prions
por: Bremer, Juliane, et al.
Publicado: (2009)

Expression of alpha-1-antichymotrypsin in prostate carcinoma.
por: Cho, N. H., et al.
Publicado: (1997)

Prion2022-pushing the boundaries
por: Zerr, Inga
Publicado: (2023)

Aerosols Transmit Prions to Immunocompetent and Immunodeficient Mice
por: Haybaeck, Johannes, et al.
Publicado: (2011)

Sympathetic Prions
por: Glatzel, Markus, et al.
Publicado: (2001)

Analysis of Prion Strains by PrP(Sc) Profiling in Sporadic Creutzfeldt–Jakob Disease
por: Schoch, Gaby, et al.
Publicado: (2006)

Correction: Aerosols transmit prions to immunocompetent and immunodeficient mice
por: Haybaeck, Johannes, et al.
Publicado: (2016)

Intraepithelial and Interstitial Deposition of Pathological Prion Protein in Kidneys of Scrapie-Affected Sheep
por: Ligios, Ciriaco, et al.
Publicado: (2007)

Human prion diseases: progress in clinical trials
por: Zerr, Inga
Publicado: (2013)

Prion 2022 Conference abstracts: pushing the boundaries
por: Zerr, Inga
Publicado: (2022)

Five Questions on Prion Diseases
por: Aguzzi, Adriano, et al.
Publicado: (2012)

Recent developments in the pathogenesis, diagnosis, and therapy of prion diseases
por: Aguzzi, Adriano
Publicado: (2001)

A role for astroglia in prion diseases
por: Aguzzi, Adriano, et al.
Publicado: (2017)

Prions, prionoids and pathogenic proteins in Alzheimer disease
por: Ashe, Karen H., et al.
Publicado: (2013)

Prion Peptide Uptake in Microglial Cells – The Effect of Naturally Occurring Autoantibodies against Prion Protein
por: Roettger, Yvonne, et al.
Publicado: (2013)

Engulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain–dependent manner
por: Kranich, Jan, et al.
Publicado: (2010)

Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein
por: Leske, Henning, et al.
Publicado: (2017)

Dangerous Liaisons between a Microbe and the Prion Protein
por: Aguzzi, Adriano, et al.
Publicado: (2003)

Elevated plasma α1-antichymotrypsin is a biomarker candidate for malaria patients
por: Bahk, Young Yil, et al.
Publicado: (2022)

The biological function of the cellular prion protein: an update
por: Wulf, Marie-Angela, et al.
Publicado: (2017)

The prion protein is not required for peripheral nerve de- and remyelination after crush injury
por: Henzi, Anna, et al.
Publicado: (2021)

Prion Pathogenesis in the Absence of NLRP3/ASC Inflammasomes
por: Nuvolone, Mario, et al.
Publicado: (2015)

Prion-resistant or prion-susceptible species, this is the question
por: Chianini, Francesca, et al.
Publicado: (2013)

Cystatin F is a biomarker of prion pathogenesis in mice
por: Nuvolone, Mario, et al.
Publicado: (2017)

Characteristic CSF Prion Seeding Efficiency in Humans with Prion Diseases
por: Cramm, Maria, et al.
Publicado: (2014)

Neurotoxic Antibodies against the Prion Protein Do Not Trigger Prion Replication
por: Frontzek, Karl, et al.
Publicado: (2016)

Cerebrospinal fluid neurogranin as a new player in prion disease diagnosis and prognosis
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

A clinical perspective on the utility of alpha 1 antichymotrypsin for the early diagnosis of calcific aortic stenosis
por: Martin-Rojas, Tatiana, et al.
Publicado: (2017)

Alpha-1-antichymotrypsin as a novel biomarker for diagnosis, prognosis, and therapy prediction in human diseases
por: Jin, Yanxia, et al.
Publicado: (2022)

Studies on Prion Replication in Spleen
por: Raeber, Alex J., et al.
Publicado: (2001)

The role of macrophage scavenger receptor 1 (Msr1) in prion pathogenesis
por: Li, Bei, et al.
Publicado: (2021)

Differential Toxicity of Antibodies to the Prion Protein
por: Reimann, Regina R., et al.
Publicado: (2016)

Cellular Prion Protein (PrP(c)) and Hypoxia: True to Each Other in Good Times and in Bad, in Sickness, and in Health
por: Ramljak, Sanja, et al.
Publicado: (2016)

Plasma levels of alpha-1-antichymotrypsin are elevated in patients with chronic heart failure, but are of limited prognostic value
por: Lok, S. I., et al.
Publicado: (2014)

A Coronary Artery Disease Monitoring Model Built from Clinical Data and Alpha-1-Antichymotrypsin
por: Chang, Chen-Chi, et al.
Publicado: (2022)

Ribosomal profiling during prion disease uncovers progressive translational derangement in glia but not in neurons
por: Scheckel, Claudia, et al.
Publicado: (2020)

Functionally Relevant Domains of the Prion Protein Identified In Vivo
por: Baumann, Frank, et al.
Publicado: (2009)

Unaltered Prion Pathogenesis in a Mouse Model of High-Fat Diet-Induced Insulin Resistance
por: Zhu, Caihong, et al.
Publicado: (2015)

Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer’s disease and multiple sclerosis
por: Stoeck, Katharina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hhit9gun8qpiums39tdonsdk8g